Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hassell

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Archives of Pathology & Laboratory Medicine|September 29, 2024
Harnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future DirectionsMatthew J Cecchini, Michael J Borowitz, Eric F Glassy, et al.
Indian Journal of Endocrinology and Metabolism|May 22, 2023
Ought to The Changes Within the Immunophenotype of Solid Cell Nests (SCNs) and Follicular Cells in Hashimoto's Thyroiditis be Considered as Premalignant Lesions?Tran Ngoc Dung, Nguyen Khac Tuyen, Truong Dinh Tien, et al.
Health Services Management Research|August 20, 2019
Clinician engagement in research as a path toward the learning health system: A regional survey across the northwestern United StatesElizabeth L Ciemins, Brenda L Mollis, Jeannine M Brant, et al.
Oncotarget|April 18, 2013
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Kristen M Reipas, Jennifer H Law, Nicole Couto, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Scientific Reports|November 10, 2018
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) AntagonismMitchell J Elliott, Katarzyna J Jerzak, Jessica G Cockburn, et al.
Oncogenesis|March 22, 2016
Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cellsB I Bassey-Archibong, J M Kwiecien, S B Milosavljevic, et al.
Journal of the National Cancer Institute|February 19, 2013
A cancer stem cell model for studying brain metastases from primary lung cancerSara M Nolte, Chitra Venugopal, Nicole McFarlane, et al.
American Journal of Physiology. Renal Physiology|September 15, 2005
Hypotension in NKCC1 null mice: role of the kidneysSusan M Wall, Mark A Knepper, Kathryn A Hassell, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|October 19, 2016
Establishing national noncommunicable disease surveillance in a developing country: a model for small island nationsAngela M Rose, Ian R Hambleton, Selvi M Jeyaseelan, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Archives of Pathology & Laboratory Medicine|September 29, 2024
Harnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future DirectionsMatthew J Cecchini, Michael J Borowitz, Eric F Glassy, et al.
Indian Journal of Endocrinology and Metabolism|May 22, 2023
Ought to The Changes Within the Immunophenotype of Solid Cell Nests (SCNs) and Follicular Cells in Hashimoto's Thyroiditis be Considered as Premalignant Lesions?Tran Ngoc Dung, Nguyen Khac Tuyen, Truong Dinh Tien, et al.
Health Services Management Research|August 20, 2019
Clinician engagement in research as a path toward the learning health system: A regional survey across the northwestern United StatesElizabeth L Ciemins, Brenda L Mollis, Jeannine M Brant, et al.
Oncotarget|April 18, 2013
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)Kristen M Reipas, Jennifer H Law, Nicole Couto, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Scientific Reports|November 10, 2018
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) AntagonismMitchell J Elliott, Katarzyna J Jerzak, Jessica G Cockburn, et al.
Oncogenesis|March 22, 2016
Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cellsB I Bassey-Archibong, J M Kwiecien, S B Milosavljevic, et al.
Journal of the National Cancer Institute|February 19, 2013
A cancer stem cell model for studying brain metastases from primary lung cancerSara M Nolte, Chitra Venugopal, Nicole McFarlane, et al.
American Journal of Physiology. Renal Physiology|September 15, 2005
Hypotension in NKCC1 null mice: role of the kidneysSusan M Wall, Mark A Knepper, Kathryn A Hassell, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|October 19, 2016
Establishing national noncommunicable disease surveillance in a developing country: a model for small island nationsAngela M Rose, Ian R Hambleton, Selvi M Jeyaseelan, et al.
Pageof 22